Andrew Chatfield

Coronary and Structural Interventional Cardiologist at Wellington Regional Hospital, New Zealand

[Ali S. Husain د.علي صاحب حسين @AliSahebHusain]

5-Year TEE and CT follow-up after TTVR using the EVOQUE valve, there was normal leaflet function with no signs of degeneration! Our paper is now available @EuroInterventio

https://t.co/zvDP1VwcRk

[Ali S. Husain د.علي صاحب حسي�� @AliSahebHusain]

A strategy of routine postdilatation at nominal volume (double tap) post BE-TAVR resulted in improved THV expansion with no safety concerns! Our paper is now out @EuroInterventio

https://t.co/rLjG5xr914

[EuroIntervention @EuroInterventio]

Bench evaluation of the novel DurAVR THV:
In native, ViV, and redo-TAVI simulations, DurAVR showed consistently larger EOAs, lower gradients, and minimal pinwheeling vs contemporary THVs. @David_Meier_ @sellers_steph

#TAVI #StructuralHeart
https://t.co/y744ySmJ0R

[Stephanie Sellers @sellers_steph]

@CardioUBC @ubc_cci @UBC_Radiology @PHCResearch @HLIStPauls @GauravGulsin @David_Meier_ @DrHodaHatoum

[EuroIntervention @EuroInterventio]

Next-day discharge post-TAVI using ACURATE, Evolut, and SAPIEN valves was not associated with higher 30-day readmissions or mortality in pacemaker-naïve patients. Results support minimalist discharge protocols. #EAPCI #CardiologyResearch #TAVI @RodrigoBagur https://t.co/EhcPKYezJr

[EuroIntervention @EuroInterventio]

This bench study evaluated the effects of pre- and post-dilatation on the expansion of balloon-expandable transcatheter heart valves during #redoTAVI. Full expansion of the redo valve, confirmed by micro-CT and hydrodynamic testing, was achieved only when a SAPIEN 3 was implanted into another SAPIEN 3 with both pre- and post-dilatation. @David_Meier_ #structuralcardiology #heartvalve

https://t.co/2ecDyze023

[Thomas Pilgrim @ThomPilgrim]

Fibrotic versus calcific aortic stenosis in patients undergoing TAVR. https://t.co/kHgw65A4Sb
@AMaznyczka @DomAngellotti @DaijiroTomii @chrisgraeni @DaryoushSamim @pbaekke @StefanStortecky

[Stephanie Sellers @sellers_steph]

New from the CV Translational Lab & Explant Valve Registry: redo-TAVI with the SAPIEN 3 in degenerated calcified CoreValve / Evolut @David_Meier_ @GilbertTangMD @ubc_cci @HLIStPauls @PHCResearch @CardioUBC @bapat_savrtavr @ShinFukuharaMD @EuroInterventio
https://t.co/SfhKwnYlq6

[EuroIntervention @EuroInterventio]

Redo-TAVI: Expanding the SAPIEN 3 valve within another SAPIEN (XT or S3) improves with pre- and post-dilatation, reaching full expansion only in the S3-in-S3 configuration. CT imaging is crucial to guide the procedure and optimize outcomes. #EIJBestOF
https://t.co/TRgHAL9TfL

[CJC Journals @CJCJournals]

The Vancouver Facilitated TAVI Clinical Pathway can potentially increase access to #TAVI and reduce inequity in TAVI care. Read more in #CJCO 👉 https://t.co/wm5qiQy0gC #OpenAccess

[Stephanie Sellers @sellers_steph]

Join us tomorrow to discuss applications of computational modeling in TAVR wtih @David_Meier_ @AIhdayhid @DrHodaHatoum and @Zahra_Motamed!
Register at: https://t.co/4Z6byinYHe
@UBCmedicine @HLIStPauls @CardioUBC @PHCResearch

[Ali S. Husain د.علي صاحب حسين @AliSahebHusain]

Postdilatation using the same THV system balloon at the same volume (double tap) does work. Here, we highlight the potential benefit of the double tap technique to treat PVL and improve THV expansion in high-risk annuli. @EuroInterventio @escardio
https://t.co/kjxHshfxfN

[Stephanie Sellers @sellers_steph]

Join our next CV Translational Seminar Series discussion on redo TAVR with @David_Meier_ @GilbertTangMD and @Miho_Fukui_ .
Register at: https://t.co/nxPUgMm9nM
@ubc_cci @HLIStPauls @Providence_Hlth @CardioUBC @UBCDoM @CHVI85209027

[Thomas Nestelberger @thomas_nest]

First #TAVI Sapien S3 Ultra Resilia @UniSpitalBasel Switzerland in a challenging tortouos and horzontal aorta with a great result and a great team. @FelixMahfoud @swissCTO @J_Boeddinghaus Christoph Kaiser, Yves Bayard, Mohamed Bayoumi

[Amr Abbas, MD, MSc @amrabbasmd]

A deep dive in the SMART trial from one of the exceptional leaders in the field. @BeaumontCards @BeaumontIC @BrianRenard1 @IvanHanson @SimonDixonMBChB

[Andrew Chatfield @agchatfield]

@hahn_rt @willsuh76 @PPibarot @amrabbasmd @modine_thomas @djc795 @mmamas1973 @ditchhaporia @athenapoppas Thank you !. Think there a is a typo in take home messages about SEVs having higher residual gradients also pacemaker and stroke trends between the different platforms

[JACC Journals @JACCJournals]

In this first long-term follow-up report of #TMVR with the SM3 device, there was normal prosthetic leaflet function with no sign of degeneration at 5 years. https://t.co/jL4Fzll3s9

#JACCINT @AliSahebHusain @myriam_akodad @David_Meier_

[EuroIntervention @EuroInterventio]

This bench study suggested that BVF performed after ViV offers the largest haemodynamic benefit without any long-term trade-offs in terms of THV performance or structural valve damage. #EIJBestOf https://t.co/AjAuV59O33

[Ali S. Husain د.علي صاحب حسين @AliSahebHusain]

Take a peek at our first publication of the new year!

❗️ Pannus can pose challenges for TMViV procedures.
❗️“watermelon seeding” phenomenon.
❗️ In our case, THV migrated ventricularly.
❗️ Another THV deployed to prevent embolization.

https://t.co/SQ7fKglc8m

@JACCJournals

[Ali S. Husain د.علي صاحب حسين @AliSahebHusain]

It was a pleasure to have participated at #LondonValve2023 with Dr. John Webb. TF TAVI using a Sapien X4 Valve. @PCRonline #PCRLV #CardioTwitter